These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9047247

  • 41. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D.
    Oncogene; 1999 Apr 01; 18(13):2241-51. PubMed ID: 10327070
    [Abstract] [Full Text] [Related]

  • 42. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
    Itamochi H, Kigawa J, Sultana H, Iba T, Akeshima R, Kamazawa S, Kanamori Y, Terakawa N.
    Jpn J Cancer Res; 2002 Jun 01; 93(6):723-8. PubMed ID: 12079522
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S, Wang D, Zhang S, Huang X, Wang D, Ijaz M, Shi Y.
    Cancer Chemother Pharmacol; 2017 Oct 01; 80(4):685-696. PubMed ID: 28779263
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
    Shi B, Yaremko B, Hajian G, Terracina G, Bishop WR, Liu M, Nielsen LL.
    Cancer Chemother Pharmacol; 2000 Oct 01; 46(5):387-93. PubMed ID: 11127943
    [Abstract] [Full Text] [Related]

  • 53. Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells.
    Ishikawa T, Kamiyama M, Hisatomi H, Ichikawa Y, Momiyama N, Hamaguchi Y, Hasegawa S, Narita T, Shimada H.
    Cancer Lett; 1999 Jul 01; 141(1-2):187-94. PubMed ID: 10454261
    [Abstract] [Full Text] [Related]

  • 54. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
    Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1317-24. PubMed ID: 16489089
    [Abstract] [Full Text] [Related]

  • 55. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
    Nukatsuka M, Fujioka A, Nakagawa F, Oshimo H, Kitazato K, Uchida J, Sugimoto Y, Nagayama S, Fukushima M.
    Int J Oncol; 2004 Dec 15; 25(6):1531-6. PubMed ID: 15547687
    [Abstract] [Full Text] [Related]

  • 56. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
    Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, Fu L, Dong JT.
    Oncotarget; 2016 Feb 02; 7(5):5702-14. PubMed ID: 26744318
    [Abstract] [Full Text] [Related]

  • 57. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
    Chahinian AP, Mandeli JP, Gluck H, Naim H, Teirstein AS, Holland JF.
    J Surg Oncol; 1998 Feb 02; 67(2):104-11. PubMed ID: 9486781
    [Abstract] [Full Text] [Related]

  • 58. Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative.
    Rose WC, Lee FY, Golik J, Kadow J.
    Cancer Chemother Pharmacol; 2000 Feb 02; 46(3):246-50. PubMed ID: 11021743
    [Abstract] [Full Text] [Related]

  • 59. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
    Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7158s-7163s. PubMed ID: 16203816
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.